Invictus RG (Singapore)’s Usana Health Sciences USNA Stock Holding History

Invictus RG (Singapore)’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,522	Closed	-$437K	–	408
2015 Q3	$437K	Buy	6,522 +3,784	+138%	+$268K	0.41%	56
2015 Q2	$187K	Sell	2,738 -8,158	-75%	-$518K	0.17%	229
2015 Q1	$605K	Buy	10,896 +1,172	+12%	+$60.1K	0.58%	28
2014 Q4	$499K	Buy	+9,724	New	+$477K	0.54%	28
2013 Q4	–	Sell	-7,956	Closed	-$345K	–	692
2013 Q3	$345K	Buy	+7,956	New	+$319K	0.29%	138

Other funds holding USNA

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invictus RG (Singapore)'s USNA Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Usana Health Sciences (USNA) in Q4 2015, closing a stake of 6,522 shares — an estimated $437K sold.

Invictus RG (Singapore) first reported a position in USNA in Q3 2013 and held it in 5 quarters. The position peaked at $605K in Q1 2015. 161 funds tracked by Wall St. Rank hold USNA as of Q4 2015.

Invictus RG (Singapore) reported no remaining Usana Health Sciences position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 6,522 Usana Health Sciences shares in Q4 2015, an estimated $437K.
Invictus RG (Singapore) first reported a position in Usana Health Sciences in Q3 2013 and held it in 5 quarters.
Invictus RG (Singapore)'s Usana Health Sciences position peaked at $605K in Q1 2015.
161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.